JDJianzhong Dang

Jianzhong Dang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jianzhong Dang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Fengyun Yu

    Laboratory for Genome Regulation and Human Health, East Lake High-Tech Development Zone, 388 Gaoxin 2nd Road, Wuhan, Hubei, 430075, China; Center for Genome Analysis, ABLife Inc., Optics Valley International Biomedical Park, East Lake High-Tech Development Zone, 388 Gaoxin 2nd Road, Wuhan, Hubei, 430075, China

    2 shared publications
  • Juan Wang

    Nephrology Department, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang District, Wuhan, Hubei, 430060, China

    2 shared publications
  • Wenliang Liao

    Nephrology Department, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang District, Wuhan, Hubei, 430060, China

    2 shared publications
  • Xiongfei Wu

    Department of Nephrology, the First Affiliated Hospital of Army Medical University, Chongqing, China

    2 shared publications
  • Yafang Tu

    Renmin Hospital of Wuhan University

    2 shared publications
  • Yaxun Wei

    Center for Genome Analysis, ABLife Inc., Optics Valley International Biomedical Park, Building 18-1, East Lake High-Tech Development Zone, 388 Gaoxin 2nd Road, Wuhan, Hubei 430075, China

    2 shared publications

Latest Publications

  • Tristetraprolin-RNA interaction map reveals a novel TTP-RelB regulatory network for innate immunity gene expression

    by Yafang Tu, Xiongfei Wu, Fengyun Yu, Jianzhong Dang, Yaxun Wei, Han Yu, Wenliang Liao, Yi Zhang, Juan Wang


  • Open Access

    Tristetraprolin specifically regulates the expression and alternative splicing of immune response genes in HeLa cells

    by Yafang Tu, Xiongfei Wu, Fengyun Yu, Jianzhong Dang, Juan Wang, Yaxun Wei, Zhitao Cai, Zhipeng Zhou, Wenliang Liao, Lian Li, et al.

    Tristetraprolin (TTP) is an RNA binding protein that plays a critical role in regulating proinflammatory immune responses by destabilizing target mRNAs via binding to their AU-rich elements (AREs) in the 3′-UTRs of mRNAs. A recent CLIP-seq study revealed that TTP-binding sites are enriched in the intronic regions of RNA. TTP is also a nuclear protein that exhibits putative DNA-binding activity. These features suggested that TTP might regulate gene transcription and/or alternative splicing of pre-mRNAs in the absence of stimulation. To elucidate the regulatory pattern of TTP, we cloned and overexpressed the human TTP-encoding gene, ZFP36, in HeLa cells in the absence of inflammatory stimuli. The transcriptomes of the control and ZFP36-overexpressing cells were sequenced and subjected to analysis and validation. Upon ZFP36 overexpression, the expression of genes associated with innate immunity, including those in the type I interferon signaling pathway and viral response, were specifically upregulated, implying a transcriptional regulatory mechanism associated with the predicted DNA binding activity of TTP. TTP preferentially regulated the alternative splicing of genes involved in the positive regulation of the I-κB/NF-κB cascade and the TRIF-dependent toll-like receptor, MAPK, TNF, and T cell receptor signaling pathways. Our findings indicated that TTP may regulate the immune response via the regulation of alternative splicing and potentially transcription, which greatly expands the current understanding of the mechanisms of TTP-mediated gene regulation.